Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials
Open Access
- 28 May 2016
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 178, 135-144
- https://doi.org/10.1016/j.ahj.2016.05.010
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 38 references indexed in Scilit:
- Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesNew England Journal of Medicine, 2015
- LDL cholesterol: controversies and future therapeutic directionsThe Lancet, 2014
- Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular EventsJournal of the American College of Cardiology, 2014
- Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart DiseaseJournal of the American College of Cardiology, 2012
- The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trialsThe Lancet, 2012
- Effect of Two Intensive Statin Regimens on Progression of Coronary DiseaseNew England Journal of Medicine, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- APCSK9Missense Variant Associated with a Reduced Risk of Early-Onset Myocardial InfarctionNew England Journal of Medicine, 2008
- Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialThe Lancet, 2004